SAN DIEGO, Aug. 20, 2019 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), the leader in spine technology innovation, focused
on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, today announced the commercial
launch of Modulus® TLIF-A, a porous titanium spine implant
engineered for the transforaminal lumbar interbody fusion (TLIF)
procedure. This offering completes the Company's Advanced Materials
Science™ (AMS) portfolio for all major posterior interbody
fusion techniques used in TLIF, the most commonly performed
procedure in the spine industry.
The availability of Modulus TLIF-A further extends NuVasive's
technology offerings in the spinal deformity market given its
differentiated ability to provide anterior column support, increase
segmental lordosis and maximize capability to restore sagittal
alignment. This solution increases the Company's footprint in the
U.S. interbody device market, which is estimated to be more than
$1.2 billion, and extends its entire
AMS portfolio to a global patient audience with significant market
share in anteriorly placed TLIF implants.1 Furthermore,
the system is designed to work seamlessly with the Company's
MAS® TLIF and MAS Midline access systems allowing
customization options to specific surgical techniques.
"The Modulus TLIF-A system is the perfect synergy between
optimized material properties and deliverability," said
Jeffrey L. Gum, MD, orthopedic
surgeon at the Norton Leatherman Spine Center. "The lattice design
allows for improved imaging characteristics, a prime environment to
promote fusion and an ideal modulus of
elasticity. Additionally, the system optimizes surgical
workflow by utilizing a single instrument for implant insertion and
articulation."
Modulus TLIF-A is an anteriorly placed implant featuring a
porous titanium surface technology that is designed to promote bone
in-growth and bone on-growth. Animal studies also demonstrated
stronger osseointegration than solid implants with smooth or rough
surfaces.2-5 This optimized lattice structure enables
enhanced imaging for visualization of spinal fusion compared to
solid titanium interbody implants.
"This complete portfolio offering for the thoracolumbar
posterior procedures space is yet another example of NuVasive's
commitment to deliver differentiated technology that supports
better patient outcomes," said Matt
Link, president of NuVasive. "NuVasive's implants are
designed to combine the inherent benefits of porosity with the
advantageous material properties of PEEK and titanium to create
implants intelligently designed for fusion, which we believe out
performs traditional and competitive implants in the market."
In June, the company announced the launch of Modulus TLIF-O,
integrating the Modulus technology with an implant designed with a
lordosis cut in the oblique plane to maximize sagittal correction
without introducing the undesired coronal deformity commonly seen
with standard oblique implant offerings. With the availability of
Modulus TLIF-A, the company plans to launch its comprehensive
Advanced Materials Science TLIF portfolio in the global market
later this year.
About NuVasive
NuVasive, Inc. (NASDAQ:
NUVA) is the leader in spine technology innovation, focused on
transforming spine surgery and beyond with minimally disruptive,
procedurally integrated solutions designed to deliver reproducible
and clinically-proven surgical outcomes. The Company's portfolio
includes access instruments, implantable hardware, biologics,
software systems for surgical planning, navigation and imaging
solutions, magnetically adjustable implant systems for spine and
orthopedics, and intraoperative monitoring service offerings. With
more than $1 billion in revenues,
NuVasive has approximately 2,600 employees and operates in more
than 50 countries serving surgeons, hospitals and patients. For
more information, please visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions
you that statements included in this news release that are not a
description of historical facts are forward-looking statements that
involve risks, uncertainties, assumptions and other factors which,
if they do not materialize or prove correct, could cause NuVasive's
results to differ materially from historical results or those
expressed or implied by such forward-looking statements. The
potential risks and uncertainties which contribute to the uncertain
nature of these statements include, among others, risks associated
with acceptance of the Company's surgical products and procedures
by spine surgeons, development and acceptance of new products or
product enhancements, clinical and statistical verification of the
benefits achieved via the use of NuVasive's products (including the
iGA® platform), the Company's ability to effectually manage
inventory as it continues to release new products, its ability to
recruit and retain management and key personnel, and the other
risks and uncertainties described in NuVasive's news releases and
periodic filings with the Securities and Exchange Commission.
NuVasive's public filings with the Securities and Exchange
Commission are available at www.sec.gov. NuVasive assumes no
obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
1U.S. Market Report Suite for Spinal implants and VCF
2017-2023, iData Research Inc.
2Cheng A, Cohen DJ, Kahn A, et al. Laser sintered porous
Ti-6Al-4V implants stimulate vertical bone growth. Ann Biomed
Eng 2017;45(8):2025-35.
3Guyer RD, Abitbol JJ, Ohnmeiss DD, et al. Evaluating
osseointegration into a deeply porous titanium scaffold: A
biomechanical comparison with PEEK and allograft. Spine
2016;41(19):E1146-50.
4Svehla M, Morberg P, Zicat B, et al. Morphometric and
mechanical evaluation of titanium implant integration: comparison
of five surface structures. J Biomed Mater Res
2000;51(1):15-22.
5Torstrick FB, Safranski DL, Burkus JK, et al. Getting
PEEK to stick to bone: The development of porous PEEK for interbody
devices. Tech Orthop 2017;32(3):9.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nuvasive-expands-its-advanced-materials-science-portfolio-to-offer-porous-titanium-spine-implants-for-all-tlif-procedures-300903958.html
SOURCE NuVasive, Inc.